{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:18:03Z","timestamp":1776453483574,"version":"3.51.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007241","name":"Paris-Saclay University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003100","name":"French Federation of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007805","name":"Fondation du Coll\u00e8ge de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021804","name":"College de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Foundation for Medical Research","doi-asserted-by":"publisher","award":["PBR201810007643"],"award-info":[{"award-number":["PBR201810007643"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cjca.2024.11.034","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:17:30Z","timestamp":1734005850000},"page":"911-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Metabolically Resistant Apelin-17 Analogue LIT01-196 Reduces Cardiac Dysfunction and Remodelling in Heart Failure After Myocardial Infarction"],"prefix":"10.1016","volume":"41","author":[{"given":"Pierre-Emmanuel","family":"Girault-Sotias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Deloux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"De Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Rich\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Daubeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Iturrioz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ara","family":"Parlakian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Berdeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onnik","family":"Agbulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne Emmanuelle","family":"Boitard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-0401","authenticated-orcid":false,"given":"Catherine","family":"Llorens-Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2024.11.034_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","article-title":"Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure","volume":"63","author":"Dzau","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.11.034_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1524-6175.2005.04486.x","article-title":"Cardioprotection: the role of beta-blocker therapy","volume":"7","author":"Egan","year":"2005","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cjca.2024.11.034_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/14656566.6.3.507","article-title":"VALIANT (VALsartan In Acute myocardial iNfarcTion) trial","volume":"6","author":"Maggioni","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cjca.2024.11.034_bib4","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1161\/01.CIR.95.12.2643","article-title":"Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial","volume":"95","author":"Pfeffer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.11.034_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacbts.2021.10.018","article-title":"Optimizing foundational therapies in patients with HFrEF: how do we translate these findings into clinical care?","volume":"7","author":"Sharma","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2024.11.034_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00109-011-0801-z","article-title":"Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides","volume":"90","author":"Calvieri","year":"2012","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.cjca.2024.11.034_bib7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.117.10156","article-title":"Apelin is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction","volume":"70","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2024.11.034_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cjca.2024.11.034_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A\u00a0human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O\u2019Dowd","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.cjca.2024.11.034_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.735515","article-title":"Apelin and vasopressin: the yin and yang of water balance","volume":"12","author":"Girault-Sotias","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.cjca.2024.11.034_bib11","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.0403518101","article-title":"Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release","volume":"101","author":"De Mota","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2024.11.034_bib12","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/en.2014-1257","article-title":"Apelin counteracts vasopressin-induced water reabsorption via cross talk between apelin and vasopressin receptor signaling pathways in the rat collecting duct","volume":"155","author":"Hus-Citharel","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.cjca.2024.11.034_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1096\/fj.201600784R","article-title":"Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects","volume":"31","author":"Gerbier","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.cjca.2024.11.034_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2024.11.034_bib15","doi-asserted-by":"crossref","first-page":"H1904","DOI":"10.1152\/ajpheart.00686.2009","article-title":"Endogenous regulation of cardiovascular function by apelin-APJ","volume":"297","author":"Charo","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2024.11.034_bib16","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"Kuba","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2024.11.034_bib17","article-title":"Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues","volume":"2","author":"Wang","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2024.11.034_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejheart.2005.10.007","article-title":"Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure","volume":"8","author":"Chong","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2024.11.034_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-291X(03)01424-4","article-title":"Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure","volume":"308","author":"F\u00f6ldes","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cjca.2024.11.034_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCHEARTFAILURE.111.000077","article-title":"Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure","volume":"6","author":"Barnes","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2024.11.034_bib21","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/eurheartj\/ehr389","article-title":"Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1","volume":"33","author":"Pchejetski","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2024.11.034_bib22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bcp.2007.12.015","article-title":"The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential","volume":"75","author":"Japp","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cjca.2024.11.034_bib23","first-page":"222","article-title":"Apelin-induced cardioprotection against ischaemia\/reperfusion injury: roles of epidermal growth factor and Src","author":"Folino","year":"2018","journal-title":"Acta Physiol Oxf Engl"},{"key":"10.1016\/j.cjca.2024.11.034_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41467-020-20560-y","article-title":"A\u00a0metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia","volume":"12","author":"Flahault","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cjca.2024.11.034_bib26","first-page":"815","article-title":"QGC606, a best-in-class orally active centrally acting aminopeptidase A inhibitor prodrug, for treating heart failure following myocardial infarction","volume":"38","author":"Boitard","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2024.11.034_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132898","article-title":"Cardiovascular response to small-molecule APJ activation","volume":"5","author":"Ason","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cjca.2024.11.034_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2024.11.034_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.56.070187.002143","article-title":"Intracellular calcium homeostasis","volume":"56","author":"Carafoli","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cjca.2024.11.034_bib30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ymthe.2017.11.007","article-title":"Therapeutic benefit and gene network regulation by combined gene transfer of apelin, FGF2, and SERCA2a into ischemic heart","volume":"26","author":"Renaud-Gabardos","year":"2018","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"10.1016\/j.cjca.2024.11.034_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fphar.2014.00005","article-title":"The role of CaMKII regulation of phospholamban activity in heart disease","volume":"5","author":"Mattiazzi","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cjca.2024.11.034_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pharmthera.2005.04.001","article-title":"Emerging roles of apelin in biology and medicine","volume":"107","author":"Kleinz","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2024.11.034_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007351","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of a small-molecule APJ (apelin receptor) agonist, BMS-986224, as a potential treatment for heart failure","volume":"14","author":"Gargalovic","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2024.11.034_bib34","first-page":"1893","article-title":"The role of BNP testing in heart failure","volume":"74","author":"Doust","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.cjca.2024.11.034_bib35","article-title":"Excessive hypoxia-inducible factor-1\u03b1 expression induces cardiac rupture via p53-dependent apoptosis after myocardial infarction","volume":"10","author":"Ikeda","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2024.11.034_bib36","doi-asserted-by":"crossref","first-page":"H605","DOI":"10.1152\/ajpheart.00366.2012","article-title":"Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction","volume":"303","author":"Li","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2024.11.034_bib37","doi-asserted-by":"crossref","first-page":"H2308","DOI":"10.1152\/ajpheart.01177.2010","article-title":"Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia","volume":"300","author":"Rastaldo","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2024.11.034_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2024.11.034_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/cvr\/cvp056","article-title":"Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-\u03b2-stimulated collagen production by cardiac fibroblasts","volume":"82","author":"Gellings Lowe","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2024.11.034_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejheart.2008.02.011","article-title":"Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure","volume":"10","author":"Koitabashi","year":"2008","journal-title":"Eur J Heart Fail"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24012583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24012583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:58:13Z","timestamp":1760072293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X24012583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0828282X24012583"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2024.11.034","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Metabolically Resistant Apelin-17 Analogue LIT01-196 Reduces Cardiac Dysfunction and Remodelling in Heart Failure After Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}